Desk› Healthcare› Acutaas Chemicals Ltd

Acutaas Chemicals Ltd

BSE 543349 ACUTAAS INE00FF01025

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 500

Filing rhythm · 30 trading days

10 filings · 5 material · busiest 2026-07-24

What it files

General2 Newspaper Publication1 Concall Transcript1 Board Outcome1 Results1 Press Release1 Investor Presentation1 Board Meeting1

Filings

10 in the window

24 August 2026

Newspaper Publication

Newspaper Publication

Newspaper Publication in respect of 19th AGM of the company scheduled to be held on Thursday, September 24, 2026 is attached

Company Update / Newspaper Publication View filing →
18 August 2026

General

Intimation Under Regulation 30 Of SEBI LODR Regulations, 2015 - Approval Under ECMS Scheme

We wish to inform you that, Ministry of Electronics and Information Technology has accorded its approval for the incentive package under the ECMS scheme as per the details attached

Company Update / General View filing →
28 July 2026

Concall Transcript

Earnings Call Transcript

Transcript of Earnings Call Q1 FY27 financial results held on July 24, 2026 is enclosed.

Company Update / Earnings Call Transcript View filing →
24 July 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting Held On July 24, 2026

The Board of Directors of the Company at their meeting held on Friday, July 24, 2026, inter alia, considered & approved Unaudited Standalone & Consolidated Financial Results of the Company ....

Board Meeting / Outcome of Board Meeting View filing →
24 July 2026

Results

Unaudited Standalone And Consolidated Financial Results For First Quarter Ended June 30, 2026

Unaudited Financial Results for the quarter ended June 30, 2026 is enclosed.

Result / Financial Results View filing →
24 July 2026

Press Release

Press Release / Media Release

Press Release discussing the financial results of first quarter ended as on June 30, 2026 is attached.

Company Update / Press Release / Media Release View filing →
24 July 2026

Investor Presentation

Investor Presentation

Investor Presentation on financial results for the first quarter ended June 30, 2026 is attached.

Company Update / Investor Presentation View filing →
24 July 2026

General

Earnings Call Recording Pursuant To SEBI (LODR) Regulations, 2015

Recording of the Earnings Call held on July 24, 2026 is enclosed

Company Update / General View filing →
20 July 2026

Board Meeting

Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2026 Scheduled On July 24, 2026.

Acutaas Chemicals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve Unaudited standalone & consolidated ....

Board Meeting / Board Meeting View filing →
20 July 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Intimation of Earnings conference call scheduled on July 24, 2026 at 04.00 P.M. (IST)

Company Update / Analyst / Investor Meet View filing →